246 related articles for article (PubMed ID: 23320002)
1. Measurements of treatment response in childhood acute leukemia.
Campana D; Coustan-Smith E
Korean J Hematol; 2012 Dec; 47(4):245-54. PubMed ID: 23320002
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia.
Inaba H; Coustan-Smith E; Cao X; Pounds SB; Shurtleff SA; Wang KY; Raimondi SC; Onciu M; Jacobsen J; Ribeiro RC; Dahl GV; Bowman WP; Taub JW; Degar B; Leung W; Downing JR; Pui CH; Rubnitz JE; Campana D
J Clin Oncol; 2012 Oct; 30(29):3625-32. PubMed ID: 22965955
[TBL] [Abstract][Full Text] [Related]
3. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia.
Cloos J; Harris JR; Janssen JJWM; Kelder A; Huang F; Sijm G; Vonk M; Snel AN; Scheick JR; Scholten WJ; Carbaat-Ham J; Veldhuizen D; Hanekamp D; Oussoren-Brockhoff YJM; Kaspers GJL; Schuurhuis GJ; Sasser AK; Ossenkoppele G
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553571
[TBL] [Abstract][Full Text] [Related]
5. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
6. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation.
Wang Z; Guo M; Zhang Y; Xu S; Cheng H; Wu J; Zhang W; Hu X; Yang J; Wang J; Tang G
Int J Lab Hematol; 2019 Oct; 41(5):607-614. PubMed ID: 31162830
[TBL] [Abstract][Full Text] [Related]
7. Understanding the clinical implications of minimal residual disease in childhood leukemia.
Mandrell BN; Pritchard M
J Pediatr Oncol Nurs; 2006; 23(1):38-44. PubMed ID: 16689404
[TBL] [Abstract][Full Text] [Related]
8. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR
J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024
[TBL] [Abstract][Full Text] [Related]
9. New approaches for the detection of minimal residual disease in acute myeloid leukemia.
van Rhenen A; Moshaver B; Ossenkoppele GJ; Schuurhuis GJ
Curr Hematol Malig Rep; 2007 May; 2(2):111-8. PubMed ID: 20425359
[TBL] [Abstract][Full Text] [Related]
10. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Neale GA; Coustan-Smith E; Pan Q; Chen X; Gruhn B; Stow P; Behm FG; Pui CH; Campana D
Leukemia; 1999 Aug; 13(8):1221-6. PubMed ID: 10450750
[TBL] [Abstract][Full Text] [Related]
11. Detection and management of acute myeloid leukemia measurable residual disease: is it standard of care?
Paterno G; Del Principe MI; Venditti A
Curr Opin Hematol; 2020 Mar; 27(2):81-87. PubMed ID: 31895104
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in acute leukemia by flow cytometry.
Campana D; Coustan-Smith E
Cytometry; 1999 Aug; 38(4):139-52. PubMed ID: 10440852
[TBL] [Abstract][Full Text] [Related]
13. Progress of minimal residual disease studies in childhood acute leukemia.
Campana D
Curr Hematol Malig Rep; 2010 Jul; 5(3):169-76. PubMed ID: 20467922
[TBL] [Abstract][Full Text] [Related]
14. Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making.
Tomlinson B; Lazarus HM
Expert Rev Hematol; 2017 Jun; 10(6):563-574. PubMed ID: 28475434
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease detection using flow cytometry: Applications in acute leukemia.
Chatterjee T; Mallhi RS; Venkatesan S
Med J Armed Forces India; 2016 Apr; 72(2):152-6. PubMed ID: 27257325
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
Liu YR; Zhang LP; Chang Y; Cheng YF; Fu JY; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):302-5. PubMed ID: 16875577
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
San Miguel JF; Martínez A; Macedo A; Vidriales MB; López-Berges C; González M; Caballero D; García-Marcos MA; Ramos F; Fernández-Calvo J; Calmuntia MJ; Diaz-Mediavilla J; Orfao A
Blood; 1997 Sep; 90(6):2465-70. PubMed ID: 9310499
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Neale GA; Coustan-Smith E; Stow P; Pan Q; Chen X; Pui CH; Campana D
Leukemia; 2004 May; 18(5):934-8. PubMed ID: 15029212
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow.
Maurillo L; Buccisano F; Spagnoli A; Del Poeta G; Panetta P; Neri B; Del Principe MI; Mazzone C; Consalvo MI; Tamburini A; Ottaviani L; Fraboni D; Sarlo C; De Fabritiis P; Amadori S; Venditti A
Haematologica; 2007 May; 92(5):605-11. PubMed ID: 17488683
[TBL] [Abstract][Full Text] [Related]
20. Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia.
Appelbaum FR
Best Pract Res Clin Haematol; 2013 Sep; 26(3):279-84. PubMed ID: 24309531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
